Clinical & Experimental Metastasis

, Volume 25, Issue 4, pp 335–344

Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis

  • Stéphanie Gout
  • Pierre-Luc Tremblay
  • Jacques Huot
Research Paper


Metastatic spreading is a dreadful complication of neoplastic diseases that is responsible for most deaths due to cancer. It consists in the formation of secondary neoplasms from cancer cells that have detached from the primary site. The formation of these secondary sites is not random and several clinical observations indicate that the metastatic colonization exhibits organ selectivity. This organ tropism relies mostly on the complementary adhesive interactions between the cancer cells and their microenvironment. In particular, several lines of evidence suggest that the organ selectivity of colon cancer cells for the liver involves the binding of the circulating cancer cells to endothelial E-selectin. The aim of this review is to make an integrative up-date of the mechanisms that govern the organ selectivity of the metastatic process focusing more especially on the role of selectins and selectin ligands.


Adhesion Extravasation Homing Selectins Selectin ligands Glycosylation Metastasis 



Complement regulatory protein


Death receptor 3


Extracellular signal-regulated kinase


Myosin light chain


Tumor necrosis factor


  1. 1.
    Ribatti D, Mangialardi G, Vacca A (2006) Stephen Paget and the ‘seed and soil’ theory of metastatic dissemination. Clin Exp Med 6:145–149PubMedCrossRefGoogle Scholar
  2. 2.
    Woodhouse EC, Chuaqui RF, Liotta LA (1997) General mechanisms of metastasis. Cancer 80:1529–1537PubMedCrossRefGoogle Scholar
  3. 3.
    Chambers AF, Naumov GN, Varghese HJ et al (2001) Critical steps in hematogenous metastasis: an overview. Surg Oncol Clin N Am 10:243–255PubMedGoogle Scholar
  4. 4.
    Mehlen P, Puisieux A (2006) Metastasis: a question of life or death. Nat Rev Cancer 6:449–58PubMedCrossRefGoogle Scholar
  5. 5.
    Weiss L (1990) Metastatic inefficiency. Adv Cancer Res 54:159–211PubMedCrossRefGoogle Scholar
  6. 6.
    Naumov GN, MacDonald IC, Weinmeister PM et al (2002) Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 62:2162–2168PubMedGoogle Scholar
  7. 7.
    Cameron MD, Schmidt EE, Kerkvliet N et al (2000) Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res 60:2541–2546PubMedGoogle Scholar
  8. 8.
    Luzzi KJ, MacDonald IC, Schmidt EE et al (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153:865–873PubMedGoogle Scholar
  9. 9.
    Paget D (1889) The distribution of secondary growths in cancer of the breast. Lancet 1:571–573CrossRefGoogle Scholar
  10. 10.
    Ewing J (1928) Neoplastic diseases. Saunders Edit, PhiladelphiaGoogle Scholar
  11. 11.
    Fidler IJ (1996) Critical determinants of melanoma metastasis. J Investig Dermatol Symp Proc 1:203–208PubMedGoogle Scholar
  12. 12.
    Woltmann G, McNulty CA, Dewson G et al (2000) Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow. Blood 95:3146–3152PubMedGoogle Scholar
  13. 13.
    Laferriere J, Houle F, Huot J (2002) Regulation of the metastatic process by E-selectin and stress-activated protein kinase-2/p38. Ann N Y Acad Sci 973:562–572PubMedCrossRefGoogle Scholar
  14. 14.
    Vestweber D, Blanks JE (1999) Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 79:181–213PubMedGoogle Scholar
  15. 15.
    Kannagi R, Izawa M, Koike T et al (2004) Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 95:377–384PubMedCrossRefGoogle Scholar
  16. 16.
    Tremblay PL, Auger FA, Huot J (2006) Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene 25:6563–6573PubMedCrossRefGoogle Scholar
  17. 17.
    Hu Y, Kiely JM, Szente BE et al (2000) E-selectin-dependent signaling via the mitogen-activated protein kinase pathway in vascular endothelial cells. J Immunol 165:2142–2148PubMedGoogle Scholar
  18. 18.
    Bird MI, Foster MR, Priest R et al (1997) Selectins: physiological and pathophysiological roles. Biochem Soc Trans 25:1199–1206PubMedGoogle Scholar
  19. 19.
    Vestweber D, Blanks JE (1999) Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 79:181–213PubMedGoogle Scholar
  20. 20.
    Brodt P, Fallavollita L, Bresalier RS et al (1997) Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer 71:612–619PubMedCrossRefGoogle Scholar
  21. 21.
    Witz IP (2006) The involvement of selectins and their ligands in tumor-progression. Immunol Lett 104:89–93PubMedCrossRefGoogle Scholar
  22. 22.
    Sawada R, Tsuboi S, Fukuda M (1994) Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem 269:1425–1431PubMedGoogle Scholar
  23. 23.
    Khatib AM, Fallavollita L, Wancewicz EV et al (2002) Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res 62:5393–5398PubMedGoogle Scholar
  24. 24.
    Kobayashi K, Matsumoto S, Morishima T et al (2000) Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res 60:3978–3984PubMedGoogle Scholar
  25. 25.
    Mannori G, Santoro D, Carter L et al (1997) Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin. Am J Pathol 151:233–243PubMedGoogle Scholar
  26. 26.
    Khatib AM, Kontogiannea M, Fallavollita L et al (1999) Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res 59:1356–1361PubMedGoogle Scholar
  27. 27.
    Nakamura S, Ohtani H, Watanabe Y et al (1993) In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells. Lab Invest 69:77–85PubMedGoogle Scholar
  28. 28.
    Ye C, Kiriyama K, Mistuoka C et al (1995) Expression of E-selectin on endothelial cells of small veins in human colorectal cancer. Int J Cancer 61:455–460PubMedCrossRefGoogle Scholar
  29. 29.
    Kakiuchi Y, Tsuji S, Tsujii M et al (2002) Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res 62:1567–1572PubMedGoogle Scholar
  30. 30.
    Borsig L, Wong R, Feramisco J et al (2001) Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 98:3352–3357PubMedCrossRefGoogle Scholar
  31. 31.
    Borsig L, Wong R, Hynes RO et al (2002) Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA 99:2193–2198PubMedCrossRefGoogle Scholar
  32. 32.
    Peeters CF, Ruers TJ, Westphal JR et al (2005) Progressive loss of endothelial P-selectin expression with increasing malignancy in colorectal cancer. Lab Invest 85:248–256PubMedCrossRefGoogle Scholar
  33. 33.
    Im JH, Fu W, Wang H et al (2004) Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 64:8613–8619PubMedCrossRefGoogle Scholar
  34. 34.
    Biggerstaff JP, Seth N, Amirkhosravi A et al (1999) Soluble fibrin augments platelet/tumor cell adherence in vitro and in vivo, and enhances experimental metastasis. Clin Exp Metastasis 17:723–730PubMedCrossRefGoogle Scholar
  35. 35.
    Fukuda M, Hiraoka N, Yeh JC (1999) C-type lectins and sialyl Lewis X oligosaccharides. Versatile roles in cell-cell interaction. J Cell Biol 147:467–470PubMedCrossRefGoogle Scholar
  36. 36.
    Zipin A, Israeli-Amit M, Meshel T et al (2004) Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells. Cancer Res 64:6571–6578PubMedCrossRefGoogle Scholar
  37. 37.
    Matsuura N, Narita T, Mitsuoka C et al (1997) Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases. Jpn J Clin Oncol 27:135–139PubMedCrossRefGoogle Scholar
  38. 38.
    Ito K, Ye CL, Hibi K et al (2001) Paired tumor marker of soluble E-selectin and its ligand sialyl Lewis A in colorectal cancer. J Gastroenterol 36:823–829PubMedCrossRefGoogle Scholar
  39. 39.
    Hakomori S, Kannagi R (1983) Glycosphingolipids as tumor-associated and differentiation markers. J Natl Cancer Inst 71:231–251PubMedGoogle Scholar
  40. 40.
    Ogawa J, Inoue H, Koide S (1996) Expression of alpha-1,3-fucosyltransferase type IV and VII genes is related to poor prognosis in lung cancer. Cancer Res 56:325–329PubMedGoogle Scholar
  41. 41.
    Seko A, Nagata K, Yonezawa S et al (2002) Down-regulation of Gal 3-O-sulfotransferase-2 (Gal3ST-2) expression in human colonic non-mucinous adenocarcinoma. Jpn J Cancer Res 93:507–515PubMedGoogle Scholar
  42. 42.
    Ikeda N, Eguchi H, Nishihara S et al (2001) A remodeling system of the 3′-sulfo-Lewis a and 3′-sulfo-Lewis x epitopes. J Biol Chem 276:38588–38594PubMedCrossRefGoogle Scholar
  43. 43.
    Lenter M, Levinovitz A, Isenmann S et al (1994) Monospecific and common glycoprotein ligands for E- and P-selectin on myeloid cells. J Cell Biol 125:471–81PubMedCrossRefGoogle Scholar
  44. 44.
    Steegmaier M, Levinovitz A, Isenmann S et al (1995) The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature 373:615–20PubMedCrossRefGoogle Scholar
  45. 45.
    Zou X, Shinde Patil VR, Dagia NM et al (2005) PSGL-1 derived from human neutrophils is a high-efficiency ligand for endothelium-expressed E-selectin under flow. Am J Physiol Cell Physiol 289: C415–424PubMedCrossRefGoogle Scholar
  46. 46.
    Dimitroff CJ, Descheny L, Trujillo N et al (2005) Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells. Cancer Res 65:5750–5760PubMedCrossRefGoogle Scholar
  47. 47.
    Gout S, Morin C, Houle F et al (2006) Death receptor-3, a new E-Selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation. Cancer Res 66:9117–9124PubMedCrossRefGoogle Scholar
  48. 48.
    Napier SL, Healy ZR, Schnaar RL et al (2007) Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44V and alternative sialofucosylated selectin ligands. J Biol Chem 282:3433–3441PubMedCrossRefGoogle Scholar
  49. 49.
    Tomlinson J, Wang JL, Barsky SH et al (2000) Human colon cancer cells express multiple glycoprotein ligands for E-selectin. Int J Oncol 16:347–353PubMedGoogle Scholar
  50. 50.
    Mackay CR, Terpe HJ, Stauder R et al (1994) Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124:71–82PubMedCrossRefGoogle Scholar
  51. 51.
    Aruffo A, Stamenkovic I, Melnick M et al (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303–1313PubMedCrossRefGoogle Scholar
  52. 52.
    Haynes BF, Liao HX, Patton KL (1991) The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 3:347–350PubMedGoogle Scholar
  53. 53.
    Heider KH, Dammrich J, Skroch-Angel P et al (1993) Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 53:4197–4203PubMedGoogle Scholar
  54. 54.
    Rall CJ, Rustgi AK (1995) CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma. Cancer Res 55:1831–1835PubMedGoogle Scholar
  55. 55.
    Penno MB, August JT, Baylin SB et al (1994) Expression of CD44 in human lung tumors. Cancer Res 54:1381–1387PubMedGoogle Scholar
  56. 56.
    Terpe HJ, Storkel S, Zimmer U et al (1996) Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Am J Pathol 148:453–463PubMedGoogle Scholar
  57. 57.
    Reeder JA, Gotley DC, Walsh MD et al (1998) Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Cancer Res 58:3719–3726PubMedGoogle Scholar
  58. 58.
    Hanley WD, Burdick MM, Konstantopoulos K et al (2005) CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity. Cancer Res 65:5812–5817PubMedCrossRefGoogle Scholar
  59. 59.
    Burdick MM, Chu JT, Godar S et al (2006) HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells. J Biol Chem 281:13899–13905PubMedCrossRefGoogle Scholar
  60. 60.
    Bodmer JL, Burns K, Schneider P et al (1997) TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 6:79–88PubMedCrossRefGoogle Scholar
  61. 61.
    Chinnaiyan AM, O’Rourke K, Yu GL et al (1996) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274:990–992PubMedCrossRefGoogle Scholar
  62. 62.
    Screaton GR, Xu XN, Olsen AL et al (1997) LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci USA 94:4615–4619PubMedCrossRefGoogle Scholar
  63. 63.
    Lohi O, Lehto VP (1998) ITAM motif in an apoptosis-receptor. Apoptosis 3:335–336PubMedCrossRefGoogle Scholar
  64. 64.
    Laferriere J, Houle F, Taher MM et al (2001) Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem 276:33762–33772PubMedCrossRefGoogle Scholar
  65. 65.
    Ohana-Malka O, Benharroch D, Isakov N et al (2003) Selectins and anti-CD15 (Lewis x/a) antibodies transmit activation signals in Hodgkin’s lymphoma-derived cell lines. Exp Hematol 31:1057–1065PubMedCrossRefGoogle Scholar
  66. 66.
    Minn AJ, Gupta GP, Siegel PM et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518–524PubMedCrossRefGoogle Scholar
  67. 67.
    Kaplan RN, Rafii S, Lyden D (2006) Preparing the “soil”: the premetastatic niche. Cancer Res 66:11089–11093PubMedCrossRefGoogle Scholar
  68. 68.
    Hiratsuka S, Nakamura K, Iwai S et al (2002) MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2:289–300PubMedCrossRefGoogle Scholar
  69. 69.
    Nicolson GL (1988) Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim Biophys Acta 948:175–224PubMedGoogle Scholar
  70. 70.
    Khatib AM, Auguste P, Fallavollita L et al (2005) Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol 167:749–759PubMedGoogle Scholar
  71. 71.
    Haier J, Nicolson GL (2001) The role of tumor cell adhesion as an important factor in formation of distant colorectal metastasis. Dis Colon Rectum 44:876–884PubMedCrossRefGoogle Scholar
  72. 72.
    Walzog B, Gaehtgens P (2000) Adhesion Molecules: The Path to a New Understanding of Acute Inflammation. News Physiol Sci 15:107–113PubMedGoogle Scholar
  73. 73.
    Narita T, Kawakami-Kimura N, Kasai Y et al (1996) Induction of E-selectin expression on vascular endothelium by digestive system cancer cells. J Gastroenterol 31:299–301PubMedCrossRefGoogle Scholar
  74. 74.
    Auguste P, Fallavollita L, Wang N et al (2007) The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation. Am J Pathol 170:1781–1792PubMedCrossRefGoogle Scholar
  75. 75.
    Wang HH, Qiu H, Qi K et al (2005) Current views concerning the influences of murine hepatic endothelial adhesive and cytotoxic properties on interactions between metastatic tumor cells and the liver. Comp Hepatol 4:8Google Scholar
  76. 76.
    Carrascal MT, Mendoza L, Valcarcel M et al (2003) Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium. Cancer Res 63:491–497PubMedGoogle Scholar
  77. 77.
    Kitakata H, Nemoto-Sasaki Y, Takahashi Y et al (2002) Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells. Cancer Res 62:6682–6687PubMedGoogle Scholar
  78. 78.
    Araki M, Araki K, Biancone L et al (1997) The role of E-selectin for neutrophil activation and tumor metastasis in vivo. Leukemia 11(Suppl 3):209–212PubMedGoogle Scholar
  79. 79.
    Gotsch U, Jager U, Dominis M et al (1994) Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-alpha in vivo. Cell Adhes Commun 2:7–14PubMedCrossRefGoogle Scholar
  80. 80.
    Kneuer C, Ehrhardt C, Radomski MW et al (2006) Selectins–potential pharmacological targets? Drug Discov Today 11:1034–1040PubMedCrossRefGoogle Scholar
  81. 81.
    He XY, Xu Z, Melrose J et al (1998) Humanization and pharmacokinetics of a monoclonal antibody with specificity for both E- and P-selectin. J Immunol 160:1029–1035PubMedGoogle Scholar
  82. 82.
    Hosono J, Narita T, Kimura N et al (1998) Involvement of adhesion molecules in metastasis of SW1990, human pancreatic cancer cells. J Surg Oncol 67:77–84PubMedCrossRefGoogle Scholar
  83. 83.
    Nakashio T, Narita T, Sato M et al (1997) The association of metastasis with the expression of adhesion molecules in cell lines derived from human gastric cancer. Anticancer Res 17:293–299PubMedGoogle Scholar
  84. 84.
    O I, Otvos L, Kieber-Emmons T et al (2002) Role of SA-Le(a) and E-selectin in metastasis assessed with peptide antagonist. Peptides 23:999–1010Google Scholar
  85. 85.
    Weston BW, Hiller KM, Mayben JP et al (1999) Expression of human alpha(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells. Cancer Res 59:2127–2135PubMedGoogle Scholar
  86. 86.
    Matsumoto S, Imaeda Y, Umemoto S et al (2002) Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. Br J Cancer 86:161–167PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media B.V. 2007

Authors and Affiliations

  • Stéphanie Gout
    • 1
  • Pierre-Luc Tremblay
    • 1
  • Jacques Huot
    • 1
  1. 1.Le Centre de recherche en cancérologie de l’Université Laval, L’Hôtel-Dieu de QuébecQuebecCanada

Personalised recommendations